Financhill
Sell
35

NWL Quote, Financials, Valuation and Earnings

Last price:
$4.99
Seasonality move :
0.9%
Day range:
$4.94 - $5.14
52-week range:
$4.22 - $11.78
Dividend yield:
5.49%
P/E ratio:
--
P/S ratio:
0.28x
P/B ratio:
0.79x
Volume:
9.4M
Avg. volume:
9.6M
1-year change:
-35.86%
Market cap:
$2.1B
Revenue:
$7.6B
EPS (TTM):
-$0.59
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $9.4B $10.6B $9.5B $8.1B $7.6B
Revenue Growth (YoY) -3.4% 12.83% -10.67% -14.02% -6.78%
 
Cost of Revenues $6.3B $7.2B $6.6B $5.8B $5B
Gross Profit $3.1B $3.4B $2.8B $2.4B $2.5B
Gross Profit Margin 32.81% 31.76% 29.96% 28.93% 33.61%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.2B $2.3B $2B $2B $2.1B
Other Inc / (Exp) -$1.6B -$73M -$411M -$625M -$443M
Operating Expenses $2.2B $2.3B $2B $2B $2.1B
Operating Income $890M $1.1B $803M $365M $478M
 
Net Interest Expenses $274M $256M $235M $283M $295M
EBT. Incl. Unusual Items -$1B $760M $157M -$543M -$260M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$236M $138M -$40M -$155M -$44M
Net Income to Company -$770M $622M $197M -$388M -$216M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$770M $622M $197M -$388M -$216M
 
Basic EPS (Cont. Ops) -$1.82 $1.46 $0.47 -$0.94 -$0.52
Diluted EPS (Cont. Ops) -$1.82 $1.45 $0.47 -$0.94 -$0.52
Weighted Average Basic Share $424.1M $425.3M $415.7M $414.1M $415.5M
Weighted Average Diluted Share $424.1M $428M $417.4M $414.1M $415.5M
 
EBITDA -$375M $1.3B $688M $74M $358M
EBIT -$732M $1B $392M -$260M $35M
 
Revenue (Reported) $9.4B $10.6B $9.5B $8.1B $7.6B
Operating Income (Reported) $890M $1.1B $803M $365M $478M
Operating Income (Adjusted) -$732M $1B $392M -$260M $35M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $2.3B $2.4B $1.8B $1.7B $1.6B
Revenue Growth (YoY) 21.32% 4.37% -24.41% -8.42% -5.26%
 
Cost of Revenues $1.6B $1.6B $1.3B $1.1B $1.1B
Gross Profit $731M $740M $482M $504M $503M
Gross Profit Margin 31.95% 30.99% 26.7% 30.49% 32.12%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $534M $518M $480M $462M $471M
Other Inc / (Exp) -$4M $113M -$50M -$32M -$15M
Operating Expenses $534M $518M $480M $462M $471M
Operating Income $197M $222M $2M $42M $32M
 
Net Interest Expenses $67M $59M $68M $70M $72M
EBT. Incl. Unusual Items $126M $276M -$116M -$60M -$55M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $37M $48M -$14M -$51M -$18M
Net Income to Company $89M $228M -$102M -$9M -$37M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $89M $228M -$102M -$9M -$37M
 
Basic EPS (Cont. Ops) $0.21 $0.54 -$0.25 -$0.02 -$0.09
Diluted EPS (Cont. Ops) $0.21 $0.54 -$0.25 -$0.02 -$0.09
Weighted Average Basic Share $424.9M $421.9M $413.9M $414.7M $416.8M
Weighted Average Diluted Share $427.6M $424.7M $413.9M $414.7M $416.8M
 
EBITDA $279M $411M $33M $95M $92M
EBIT $193M $335M -$48M $10M $17M
 
Revenue (Reported) $2.3B $2.4B $1.8B $1.7B $1.6B
Operating Income (Reported) $197M $222M $2M $42M $32M
Operating Income (Adjusted) $193M $335M -$48M $10M $17M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $9.8B $10.7B $8.9B $8B $7.5B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $6.6B $7.3B $6.3B $5.6B $4.9B
Gross Profit $3.2B $3.4B $2.6B $2.4B $2.5B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.2B $2.3B $2B $2B $2.1B
Other Inc / (Exp) -$137M $44M -$574M -$607M -$426M
Operating Expenses $2.2B $2.3B $2B $2B $2.1B
Operating Income $1B $1.1B $583M $405M $468M
 
Net Interest Expenses $278M $248M $244M $285M $297M
EBT. Incl. Unusual Items $603M $910M -$235M -$487M -$255M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $5M $149M -$102M -$192M -$11M
Net Income to Company $598M $761M -$133M -$295M -$244M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $598M $761M -$133M -$295M -$244M
 
Basic EPS (Cont. Ops) $1.41 $1.68 -$0.32 -$0.72 -$0.59
Diluted EPS (Cont. Ops) $1.40 $1.66 -$0.32 -$0.72 -$0.59
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $1.2B $1.5B $310M $136M $355M
EBIT $881M $1.2B $9M -$202M $42M
 
Revenue (Reported) $9.8B $10.7B $8.9B $8B $7.5B
Operating Income (Reported) $1B $1.1B $583M $405M $468M
Operating Income (Adjusted) $881M $1.2B $9M -$202M $42M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $2.3B $2.4B $1.8B $1.7B $1.6B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.6B $1.6B $1.3B $1.1B $1.1B
Gross Profit $731M $740M $482M $504M $503M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $534M $518M $480M $462M $471M
Other Inc / (Exp) -$4M $113M -$50M -$32M -$15M
Operating Expenses $534M $518M $480M $462M $471M
Operating Income $197M $222M $2M $42M $32M
 
Net Interest Expenses $67M $59M $68M $70M $72M
EBT. Incl. Unusual Items $126M $276M -$116M -$60M -$55M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $37M $48M -$14M -$51M -$18M
Net Income to Company $89M $228M -$102M -$9M -$37M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $89M $228M -$102M -$9M -$37M
 
Basic EPS (Cont. Ops) $0.21 $0.54 -$0.25 -$0.02 -$0.09
Diluted EPS (Cont. Ops) $0.21 $0.54 -$0.25 -$0.02 -$0.09
Weighted Average Basic Share $424.9M $421.9M $413.9M $414.7M $416.8M
Weighted Average Diluted Share $427.6M $424.7M $413.9M $414.7M $416.8M
 
EBITDA $279M $411M $33M $95M $92M
EBIT $193M $335M -$48M $10M $17M
 
Revenue (Reported) $2.3B $2.4B $1.8B $1.7B $1.6B
Operating Income (Reported) $197M $222M $2M $42M $32M
Operating Income (Adjusted) $193M $335M -$48M $10M $17M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $981M $440M $287M $332M $198M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.7B $1.5B $1.3B $1.2B $878M
Inventory $1.6B $2.1B $2.2B $1.5B $1.4B
Prepaid Expenses $331M -- -- -- --
Other Current Assets -- $325M $312M $296M $299M
Total Current Assets $4.6B $4.4B $4.1B $3.4B $2.8B
 
Property Plant And Equipment $1.7B $1.8B $1.8B $1.7B $1.6B
Long-Term Investments -- -- -- -- --
Goodwill $3.6B $3.5B $3.3B $3.1B $3B
Other Intangibles $3.6B $3.4B $2.6B $2.5B $2B
Other Long-Term Assets $411M $467M $691M $717M $754M
Total Assets $14.7B $14.3B $13.3B $12.2B $11B
 
Accounts Payable $1.5B $1.7B $1.1B $1B $891M
Accrued Expenses $1.2B $1.2B $1.1B $1.2B $1B
Current Portion Of Long-Term Debt $466M $3M $621M $329M $87M
Current Portion Of Capital Lease Obligations $129M $122M $121M $122M $110M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $3.6B $3.3B $3.1B $2.9B $2.4B
 
Long-Term Debt $5.1B $4.9B $4.8B $4.6B $4.5B
Capital Leases -- -- -- -- --
Total Liabilities $10.8B $10.1B $9.7B $9.1B $8.3B
 
Common Stock $448M $450M $439M $440M $442M
Other Common Equity Adj -$880M -$882M -$1B -$890M -$981M
Common Equity $3.9B $4.2B $3.5B $3.1B $2.8B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $26M -- -- -- --
Total Equity $3.9B $4.2B $3.5B $3.1B $2.8B
 
Total Liabilities and Equity $14.7B $14.3B $13.3B $12.2B $11B
Cash and Short Terms $981M $440M $287M $332M $198M
Total Debt $5.6B $4.9B $5.4B $4.9B $4.6B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $682M $344M $271M $372M $233M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.5B $1.4B $1.2B $958M $892M
Inventory $1.9B $2.3B $2.2B $1.7B $1.6B
Prepaid Expenses $272M $349M -- -- --
Other Current Assets -- -- $326M $376M $334M
Total Current Assets $4.4B $4.4B $4.1B $3.4B $3B
 
Property Plant And Equipment $1.7B $1.7B $1.8B $1.7B $1.6B
Long-Term Investments -- -- -- -- --
Goodwill $3.5B $3.5B $3.3B $3.1B $3.1B
Other Intangibles $3.5B $3B $2.6B $2.4B $2B
Other Long-Term Assets $417M $725M $699M $732M $726M
Total Assets $14.3B $14.2B $13.3B $12.1B $11.3B
 
Accounts Payable $1.5B $1.7B $1.1B $1B $1.1B
Accrued Expenses $1.1B $1.2B $1.1B $1.2B $1B
Current Portion Of Long-Term Debt $357M $3M $852M $429M $397M
Current Portion Of Capital Lease Obligations $125M $125M $121M $122M $112M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $3.4B $3.2B $3.3B $3B $2.7B
 
Long-Term Debt $5.1B $4.9B $4.8B $4.6B $4.5B
Capital Leases -- -- -- -- --
Total Liabilities $10.5B $10.2B $9.9B $9B $8.6B
 
Common Stock $450M $441M $439M $441M $445M
Other Common Equity Adj -$914M -$854M -$1B -$899M -$984M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $25M -- -- -- --
Total Equity $3.9B $4B $3.3B $3.1B $2.7B
 
Total Liabilities and Equity $14.3B $14.2B $13.3B $12.1B $11.3B
Cash and Short Terms $682M $344M $271M $372M $233M
Total Debt $5.5B $4.9B $5.6B $5B $4.9B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$770M $622M $197M -$388M -$216M
Depreciation & Amoritzation $357M $325M $296M $334M $323M
Stock-Based Compensation $41M $52M $12M $50M $74M
Change in Accounts Receivable $168M $130M $130M $67M $241M
Change in Inventories -$29M -$463M -$276M $673M $70M
Cash From Operations $1.4B $884M -$272M $930M $496M
 
Capital Expenditures $259M $289M $312M $284M $259M
Cash Acquisitions $16M -- $617M $11M $14M
Cash From Investing -$228M -$268M $343M -$199M -$151M
 
Dividends Paid (Ex Special Dividend) -$392M -$394M -$385M -$184M -$118M
Special Dividend Paid
Long-Term Debt Issued $491M -- $1.6B -- $1.7B
Long-Term Debt Repaid -$651M -$704M -$1.1B -$490M -$2B
Repurchase of Common Stock -- -- -$325M -- --
Other Financing Activities -$18M -$28M -- -$1M -$14M
Cash From Financing -$559M -$1.1B -$232M -$664M -$451M
 
Beginning Cash (CF) $371M $1B $477M $303M $361M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $645M -$527M -$161M $67M -$106M
Ending Cash (CF) $1B $477M $303M $361M $219M
 
Levered Free Cash Flow $1.2B $595M -$584M $646M $237M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $89M $228M -$102M -$9M -$37M
Depreciation & Amoritzation $86M $76M $81M $85M $75M
Stock-Based Compensation $14M $14M $11M $16M $16M
Change in Accounts Receivable $122M $14M $45M $221M $3M
Change in Inventories -$283M -$403M -$27M -$178M -$168M
Cash From Operations -$25M -$272M -$77M $32M -$213M
 
Capital Expenditures $54M $70M $83M $59M $59M
Cash Acquisitions -- $620M -- -- --
Cash From Investing -$54M $559M -$68M -$50M -$27M
 
Dividends Paid (Ex Special Dividend) -$100M -$100M -$97M -$31M -$31M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- $232M $431M $310M
Long-Term Debt Repaid -$100M -$1M -- -$331M --
Repurchase of Common Stock -- -$275M -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -$239M -$393M $128M $60M $270M
 
Beginning Cash (CF) $1B $477M $303M $361M $219M
Foreign Exchange Rate Adjustment -$14M $8M -$1M -$3M $3M
Additions / Reductions -$318M -$106M -$17M $42M $30M
Ending Cash (CF) $689M $379M $285M $400M $252M
 
Levered Free Cash Flow -$79M -$342M -$160M -$27M -$272M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $598M $761M -$133M -$295M -$244M
Depreciation & Amoritzation $352M $315M $301M $338M $313M
Stock-Based Compensation $47M $52M $9M $55M $74M
Change in Accounts Receivable -$79M $22M $161M $243M $23M
Change in Inventories -$170M -$583M $100M $522M $80M
Cash From Operations $1.4B $637M -$77M $1B $251M
 
Capital Expenditures $255M $305M $325M $260M $259M
Cash Acquisitions $16M $620M -$3M $11M $14M
Cash From Investing -$226M $345M -$284M -$181M -$128M
 
Dividends Paid (Ex Special Dividend) -$393M -$394M -$382M -$118M -$118M
Special Dividend Paid
Long-Term Debt Issued -- -- $1.8B $199M $1.5B
Long-Term Debt Repaid -$735M -$605M -$1.1B -$821M -$1.6B
Repurchase of Common Stock -- -$275M -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -$971M -$1.3B $289M -$732M -$241M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $187M -$315M -$72M $126M -$118M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $1.1B $332M -$402M $779M -$8M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $89M $228M -$102M -$9M -$37M
Depreciation & Amoritzation $86M $76M $81M $85M $75M
Stock-Based Compensation $14M $14M $11M $16M $16M
Change in Accounts Receivable $122M $14M $45M $221M $3M
Change in Inventories -$283M -$403M -$27M -$178M -$168M
Cash From Operations -$25M -$272M -$77M $32M -$213M
 
Capital Expenditures $54M $70M $83M $59M $59M
Cash Acquisitions -- $620M -- -- --
Cash From Investing -$54M $559M -$68M -$50M -$27M
 
Dividends Paid (Ex Special Dividend) -$100M -$100M -$97M -$31M -$31M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- $232M $431M $310M
Long-Term Debt Repaid -$100M -$1M -- -$331M --
Repurchase of Common Stock -- -$275M -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -$239M -$393M $128M $60M $270M
 
Beginning Cash (CF) $1B $477M $303M $361M $219M
Foreign Exchange Rate Adjustment -$14M $8M -$1M -$3M $3M
Additions / Reductions -$318M -$106M -$17M $42M $30M
Ending Cash (CF) $689M $379M $285M $400M $252M
 
Levered Free Cash Flow -$79M -$342M -$160M -$27M -$272M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Is Berkshire The Best Stock to Buy in a Bad Market?
Is Berkshire The Best Stock to Buy in a Bad Market?

Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…

Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?

The big picture trends in e‑commerce sales are clearly in…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
60
RGC alert for May 6

Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.

Buy
63
SKX alert for May 6

Skechers USA [SKX] is down 0.07% over the past day.

Sell
20
PTCT alert for May 6

PTC Therapeutics [PTCT] is down 11% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock